
Kaohsiung Medical University / Prof. Tsung-Lin Cheng
Pain Points Solved
Technology Introduction
Osteoarthritis (OA) affects tens of millions of people worldwide, causing cartilage damage and joint pain, yet there is currently no effective treatment. This technology focuses on thrombomodulin (TM), a highly evolutionarily conserved protein.
TM can promote chondrocyte growth and inhibit inflammation. By injecting TM or enhancing its expression through microRNA (miR-up-TM), OA can be effectively prevented or treated. This technology is cost-effective, easy to use, and reduces the risk of allergic reactions.

Figure 1. Role of thrombomodulin (TM) in chondrocytes and osteoarthritis (OA).

Figure 1. miR-up-TM enhances the signaling pathway from KLF2 to TM, thereby effectively protecting knee joint functio.

Figure 1. miR-up-TM increases TM expression in chondrocytes to exert anti-osteoarthritic effects.
Application Examples
Related Links
None
Patent Name and Number
TW 113116868
US 18/656,60822
Industry-Academia / Tech Transfer Partner
None
Honors and Awards
21st National Innovation Award-Academia & Research Innovation Award
Technical Contact
Mr. Hung, Assistant Manager
Kaohsiung Medical University
Tel: +886 7-3121101 ext. 2360
Email: R121084@kmu.edu.tw